Targeting and Modulating Tumor-Associated Sites with Novel Nanoparticle-Based Immunotherapies

Thumbnail

Event details

Date 29.11.2013
Hour 17:30
Speaker Laura Jeanbart, Swartz Lab (LLCB) & Hubbell Lab (LMRP)
Location
Category Thesis defenses
PUBLIC BIOENGINEERING PhD THESIS DEFENSE

Thesis supervisors: Profs. M. Swartz and J. Hubbell
Biotechnology and Bioengineering doctoral program (EDBB)
Thesis #6021

This public defense will followed by an apéritif sponsored by the Institute of Bioengineering (IBI)

Practical information

  • General public
  • Free

Organizer

Tags

nanoparticle cancer vaccine tumor-draining lymph node TRP-2 CpG CD8+ T cells myeloid-derived suppressor cells immune suppression immunotherapy

Share